The heart has been used in three successful “bridge-to-heart transplant” patients with severe heart failure who are waiting for a donor heart.
Banner-University Medical Center Phoenix became the third U.S. hospital to perform a BiVACOR total artificial heart implantation as part of the FDA’s early feasibility study.
The first implantation was performed at Houston-based Texas Heart Institute in July and the second was performed in August at Durham, N.C.-based Duke University Hospital.
The device is made of titanium and uses a magnetically levitated rotor to pump blood, replacing both heart ventricles, according to an Oct. 11 news release from Phoenix-based Banner Health.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
